Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/43857
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_PeptidesToAP3ToAP4.pdf2,56 MBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorVeloso Júnior, Paulo Henrique de Holanda-
dc.contributor.authorSimon, Karina Smidt-
dc.contributor.authorCastro, Raffael Júnio Araújo de-
dc.contributor.authorCoelho, Luísa Coutinho-
dc.contributor.authorHurtado Erazo, Fabián Andrés-
dc.contributor.authorSouza, Adolfo Carlos Barros de-
dc.contributor.authorNeves, Rogério Coutinho das-
dc.contributor.authorLozano, Viviane Furlan-
dc.contributor.authorSchwartz, Elisabeth Nogueira Ferroni-
dc.contributor.authorTavares, Aldo Henrique Fonseca Pacheco-
dc.contributor.authorMortari, Márcia Renata-
dc.contributor.authorKipnis, Ana Paula Junqueira-
dc.contributor.authorPereira, Ildinete Silva-
dc.contributor.authorBocca, Anamélia Lorenzetti-
dc.date.accessioned2022-06-01T12:58:44Z-
dc.date.available2022-06-01T12:58:44Z-
dc.date.issued2022-
dc.identifier.citationVELOSO JÚNIOR, Paulo Henrique de Holanda et al. Peptides ToAP3 and ToAP4 decrease release of inflammatory cytokines through TLR-4 blocking, Biomedicine & Pharmacotherapy, v. 118, 109152, 2019. DOI: https://doi.org/10.1016/j.biopha.2019.109152. Disponível em: https://www.sciencedirect.com/science/article/pii/S0753332219322346. Acesso em: 1 jun. 2022.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/43857-
dc.language.isoInglêspt_BR
dc.publisherElsevierpt_BR
dc.rightsAcesso Abertopt_BR
dc.titlePeptides ToAP3 and ToAP4 decrease release of inflammatory cytokines through TLR-4 blockingpt_BR
dc.typeArtigopt_BR
dc.subject.keywordAnti-inflamatóriospt_BR
dc.subject.keywordCélulas dendríticaspt_BR
dc.subject.keywordMacrófagospt_BR
dc.subject.keywordEscorpião - venenopt_BR
dc.rights.license© 2019 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC-ND licensept_BR
dc.identifier.doihttps://doi.org/10.1016/j.biopha.2019.109152pt_BR
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0753332219322346pt_BR
dc.description.abstract1Antimicrobial peptides (AMPs) are small molecules with microbicidal and immunoregulatory activities. In this study we evaluated the anti-inflammatory and antimicrobial activities of peptides ToAP3 and ToAP4, AMPs from the venom of the Brazilian scorpion Tityus obscurus. To test the peptides’ activity, murine bone marrow-derived macrophages (BMDMs) or dendritic cells (BMDCs) were stimulated with peptides plus LPS to analyze their ability to modulate cytokine release as well as phenotypic markers. For antimicrobial analysis, we evaluated the indirect activity against macrophage-internalized Cryptococcus neoformans and direct activity against Mycobacterium massiliense. Our data demonstrate that they were able to reduce TNF-α and IL-1β transcript levels and protein levels for BMDM and BMDC. Furthermore, the reduction of TNF-α secretion, before LPS- inflammatory stimuli, is associated with peptide interaction with TLR-4. ToAP4 increased MHC-II expression in BMDC, while ToAP3 decreased co-stimulatory molecules such as CD80 and CD86. Although these peptides were able to modulate the production of cytokines and molecules associated with antigen presentation, they did not increase the ability of clearance of C. neoformans by macrophages. In antimicrobial analysis, only ToAP3 showed potent action against bacteria. Altogether, these results demonstrate a promising target for the development of new immunomodulatory and anti-bacterial therapies.pt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.